TITLE

Product Patents on drugs and Medicines - A critique

AUTHOR(S)
Patil, Dinesh kumar D.
PUB. DATE
August 2012
SOURCE
Indian Streams Research Journal;Aug2012, Vol. 2 Issue 7, Special section p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
India has shifted to a new product patent regime from process patents which was considered as a transition period from 1995-200, All the developing countries and least developed countries were under an obligation to amend the Patent Laws in their respective countries to meet the norms of minimum standard as envisaged in the TRIPS Agreement although there were oppositions from all the corners of the world but the Doha declaration was brought to cover up the loop holes to protect the public health by providing flexibilities which were not clearly made out the paper discusses how it affected the general public in having access to life saving drugs and what steps can be taken in the light of stricter norms of IPR regimes.
ACCESSION #
82588919

 

Related Articles

  • Examining Patent Enforcement and Litigation in India from A Development Perspective -- A study. Palanissamy, Ayyappan // International Proceedings of Economics Development & Research;2012, Vol. 45, p5 

    Intellectual Property Rights (IPRs) have long played important roles in the innovation systems of most advanced economies. India, like many developing economies, began re-examining its approaches to IPRs when the World Trade Organization's Trade-Related Aspects of Intellectual Property (TRIPS)...

  • IP protection bill on anvil: S&T Minister.  // BioSpectrum;Apr2013, Vol. 11 Issue 4, p66 

    The article reports on Minister of Science and Technology and Earth Sciences S. Jaipal Reddy's statement over patent rights and its benefits in the Indian Parliament.

  • Defending India's IPR.  // FRPT- FMCG Snapshot;5/24/2015, p28 

    The article reports on the Indian Patents Act of 1970 (IPR) and its amendment which introduces regulations in Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement.

  • U.S. or India: Where to file for a patent first?  // Siliconindia;Jan2012, Vol. 15 Issue 1, p28 

    The article explores the advantages of filing a patent in India first and the consequences of filing it in the U.S. first if the investor resides in India. It emphasizes the need to understand the provision of the Indian Patent Law about foreign filing. It stresses the filing patents in India...

  • Patenting of Nanotechnology Invention: Issues and Challenges in India. Rastogi, Priyanka // Nanotechnology Law & Business;Winter2013, Vol. 10, p139 

    Nanotechnology is the engineering of matter at the scale of atoms and molecules where size is measured in billionth of a meter (i.e., one nanometer = one-billionth of a meter). Nanotechnology encompasses a vast field, which includes a range of technologies at the nano scale, such as,...

  • India being coaxed to relax patent laws: MSF.  // BioSpectrum;Nov2014, Vol. 12 Issue 11, p14 

    The article reports on medical humanitarian organization Medecins Sans Frontiers (MSF) which condemned the U.S. for pressuring India to relax the patent laws that govern the Indian pharmaceutical products.

  • Patients' groups voice patent fears.  // Telegraph (Calcutta, India);1/24/2015, p6 

    The article reports on the concerns of the health and patients' rights groups on the possible impact of the bilateral talks on the intellectual property rights that will allow drug companies to sell affordable generic medicines.

  • Developing Balance. Bennett, Peter A. // Drug Discovery & Development;Nov/Dec2012, Vol. 15 Issue 9, p4 

    In this article the author discusses the patents of drugs. He states that India amended its law in 2005 to comply with the Agreement on Trade-Related Intellectual Property Rights (TRIPS) of the World Trade Organization (WTO). He mentions that the patent for Pegasys hepatitis C treatment by F....

  • Change and Competitive Advantage: An Investigative Study of Indian Pharmaceutical Industry. Sharma, J. K.; Singh, K. // IUP Journal of Business Strategy;Sep2012, Vol. 9 Issue 3, p46 

    Year 2005 was an important milestone for the Indian pharmaceutical companies. With the start of the year, Indian pharmaceutical companies had to fall in line with its commitments to the World Trade Organization (WTO). The strategies pursued by the firms for the past 40 years after the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics